▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Motley Fool Staff

the_motley_fool

Recent Articles by Motley Fool Staff

Aug 1, 2016 by Motley Fool Staff

1 Reason Banks Did Well in the Second Quarter

In the first three months of the year, lower trading revenues weighed heavily on bank performances. The exact opposite was true in the second quarter.

Aug 1, 2016 by Motley Fool Staff

Banks Are as Safe as They’ve Been in Modern Memory

The Fed's recently completed stress tests prove that the nation's biggest banks are safe -- though their profitability these days isn't faring as well.

TMF Compound Interest Infographic Final Larger 2

Aug 1, 2016 by Eryn (Eryn-tern) Ratcliffe

The Secret to Long-Term Wealth

Would you rather, for one month, get $1,000 each day or a magic penny that doubles each day? A look at how compound interest works.

Aug 1, 2016 by Motley Fool Staff

Why Things Are So Inhospitable for Banks Right Now

Low interest rates are weighing heavily on bank profits, with one bank in particular bearing the brunt of it.

Jul 31, 2016 by Motley Fool Staff

2 Traits of the Best Performing Bank Stocks

Banks like U.S. Bancorp, Wells Fargo, and M&T Bank show that great banks not only generate reasonably high profitability, but do so consistently.

Jul 31, 2016 by Motley Fool Staff

How the Bank Industry Performed in the Second Quarter

Now that the nation’s biggest banks have all reported second-quarter earnings, we can get a sense for how the industry performed in the especially tumultuous three-month stretch.

Jul 30, 2016 by Motley Fool Staff

What Does The Princeton Review Mean to Match Group

Even though The Princeton Review is a strange fit with the rest of Match Group's portfolio of businesses, Match has big plans for the test-prep company that could see it contributing more to the bottom line in the future.

Jul 29, 2016 by Motley Fool Staff

Which CAR-T Developer Is the Best Buy?

Kite Pharma and Bellicum Pharmaceuticals have so far dodged safety risks that recently plagued competitor Juno Therapeutics. Here's why they might be worth owning.

GettyImages-869012362

Feb 20, 2018 by Motley Fool Staff

A Quick Guide to Asset Allocation: Stocks vs. Bonds vs. Cash

Knowing how to properly allocate your investment portfolio can help you meet your goals and manage your risks.

meeting with advisor_GettyImages-86807071

Jul 28, 2016 by Motley Fool Staff

What Is a Commingled Trust Fund?

Here's another option for investing those retirement dollars.

Jul 28, 2016 by Motley Fool Staff

Is It Safe to Buy Into "Big Soda"?

While changing consumer preferences present challenges for the industry, investors should not be selling their holdings quite yet.

Jul 28, 2016 by Motley Fool Staff

3 Stocks on Our Radar This Week

Why Tilly’s, Vail Resorts, and Buffalo Wild Wings have drawn our attention.

Jul 28, 2016 by Motley Fool Staff

What Investors Should Know About Juno Therapeutics' Recent Trial Stop and Restart

The only thing more surprising than Juno Therapeutics' surprising halt to its JCAR015 trial might be how quickly the FDA approved the trial starting again.

Jul 28, 2016 by Motley Fool Staff

How PepsiCo Inc Has Found Success in Innovation and the Defiance of Activist Investors

In the face of declining popularity for soda and other sugary beverages, CEO Indra Nooyi has a clear plan for the future of Pepsi.

Jul 28, 2016 by Motley Fool Staff

Will Nintendo Continue to Soar Following Pokemon Go's Explosive Success?

Explaining the craze around the new mobile app game, and some concerns investors should be aware of.

Jul 28, 2016 by Motley Fool Staff

Why Investors Favor Simple Banks

Complexity doesn’t necessarily mean higher returns for bank shareholders.

Jul 27, 2016 by Motley Fool Staff

The Coca-Cola Co v2.0: Smaller Company, Bigger Brand Portfolio

Refranchising of bottling operations will see the company significantly shrink both its revenue and workforce, but its number of beverage offerings is growing quickly.

Jul 27, 2016 by Motley Fool Staff

Another All-Time High for Amazon.com. Prime Matters.

The giant online retailer's impressive performance continues after an especially profitable Prime Day earlier this month.

Jul 27, 2016 by Motley Fool Staff

FTC: Herbalife Is Not a Pyramid Scheme

Lessons learned from Herbalife’s FTC investigation results, and Bill Ackman’s response to it.

factory_exterior-medium[1]

Jul 27, 2016 by Motley Fool Staff, Sean O'Reilly, and Ben Estep

Elon Musk’s Master Plan: Key Takeaways For Investors

How long-term investors should think about investing in Tesla in light of its conglomerate goals.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services